Robert W. Kaminski

2.0k total citations
57 papers, 1.5k citations indexed

About

Robert W. Kaminski is a scholar working on Endocrinology, Infectious Diseases and Immunology. According to data from OpenAlex, Robert W. Kaminski has authored 57 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Endocrinology, 44 papers in Infectious Diseases and 11 papers in Immunology. Recurrent topics in Robert W. Kaminski's work include Escherichia coli research studies (46 papers), Viral gastroenteritis research and epidemiology (41 papers) and Clostridium difficile and Clostridium perfringens research (27 papers). Robert W. Kaminski is often cited by papers focused on Escherichia coli research studies (46 papers), Viral gastroenteritis research and epidemiology (41 papers) and Clostridium difficile and Clostridium perfringens research (27 papers). Robert W. Kaminski collaborates with scholars based in United States, Switzerland and United Kingdom. Robert W. Kaminski's co-authors include Edwin V. Oaks, K. Ross Turbyfill, Kristen A. Clarkson, George H. Lowell, Chad K. Porter, Thomas C. VanCott, John R. Mascola, Vaniambadi S. Kalyanaraman, J. Terry Ulrich and Mark S. Riddle and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Robert W. Kaminski

53 papers receiving 1.5k citations

Peers

Robert W. Kaminski

ENDOC

IMMUN

EPIDE

G Losonsky United States

Fernando Noriega United States

Ghislaine Guigon France

Jennifer L. Kyle United States

George H. Lowell United States

Frederick J. Cassels United States

Jesús Agüero Spain

Eileen M. Barry United States

Han Zheng China

Ivonne Stamm Germany

G Losonsky United States

Robert W. Kaminski

772 ×0.8

811 ×0.9

ENDOC

364 ×1.1

IMMUN

226 ×1.0

208 ×1.1

EPIDE

Citations per year, relative to Robert W. Kaminski Robert W. Kaminski (= 1×) peers G Losonsky

Countries citing papers authored by Robert W. Kaminski

Since Specialization

Citations

This map shows the geographic impact of Robert W. Kaminski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Kaminski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Kaminski more than expected).

Fields of papers citing papers by Robert W. Kaminski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Kaminski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Kaminski. The network helps show where Robert W. Kaminski may publish in the future.

Co-authorship network of co-authors of Robert W. Kaminski

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Kaminski. A scholar is included among the top collaborators of Robert W. Kaminski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Kaminski. Robert W. Kaminski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Emary, Katherine R. W., Adwoa Bentsi-Enchill, Birgitte Giersing, et al.. (2025). Landscape analysis of invasive non-typhoidal salmonella (iNTS) disease and iNTS vaccine use case and demand: Report of a WHO expert consultation. Vaccine. 55. 127008–127008. 1 indexed citations

Kaminski, Robert W., Patricia B. Pavlinac, Elizabeth T. Rogawski McQuade, et al.. (2025). WHO Workshop Report: Regulatory Science to Inform Clinical Pathways for Shigella Vaccines Intended for Use in Children in Low- and Middle-Income Countries. Vaccines. 13(5). 439–439.

Bernshtein, Biana, Meagan Kelly, Deniz Cizmeci, et al.. (2024). Determinants of immune responses predictive of protection against shigellosis in an endemic zone: a systems analysis of antibody profiles and function. The Lancet Microbe. 5(10). 100889–100889. 2 indexed citations

Duplessis, Christopher, Kristen A. Clarkson, K. Ross Turbyfill, et al.. (2023). GMP manufacture of Shigella flexneri 2a Artificial Invaplex (InvaplexAR) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers. Vaccine. 41(42). 6261–6271. 3 indexed citations

Kelly, Meagan, Anjali Mandlik, Richelle C. Charles, et al.. (2023). Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry. Vaccine. 41(34). 4967–4977. 6 indexed citations

Islam, Dilara, Rawiwan Im‐Erbsin, Matthew D. Wegner, et al.. (2023). Bioactivity and efficacy of a hyperimmune bovine colostrum product- Travelan, against shigellosis in a non-Human primate model (Macaca mulatta). PLoS ONE. 18(12). e0294021–e0294021. 2 indexed citations

Clarkson, Kristen A., Chad K. Porter, Kawsar R. Talaat, et al.. (2021). Shigella -Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei. mSphere. 6(4). e0012221–e0012221. 11 indexed citations

Clarkson, Kristen A., Chad K. Porter, Kawsar R. Talaat, et al.. (2021). Shigella-Controlled Human Infection Models: Current and Future Perspectives. Current topics in microbiology and immunology. 445. 257–313. 3 indexed citations

Clarkson, Kristen A., Kawsar R. Talaat, Cristina Alaimo, et al.. (2021). Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine. EBioMedicine. 66. 103308–103308. 33 indexed citations

10.

Frenck, Robert W., Michelle Dickey, Akamol E. Suvarnapunya, et al.. (2020). Establishment of a Controlled Human Infection Model with a Lyophilized Strain of Shigella sonnei 53G. mSphere. 5(5). 15 indexed citations

11.

Clarkson, Kristen A., Robert W. Frenck, Michelle Dickey, et al.. (2020). Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G. mSphere. 5(5). 29 indexed citations

12.

Kaminski, Robert W., Marcela F. Pasetti, Kristen A. Clarkson, et al.. (2019). Consensus Report on Shigella Controlled Human Infection Model: Immunological Assays. Clinical Infectious Diseases. 69(Supplement_8). S596–S601. 21 indexed citations

13.

Maciel, Milton, Mark A. Smith, S. Poole, et al.. (2019). Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice. PLoS ONE. 14(11). e0224073–e0224073. 16 indexed citations

14.

Yu, Jigui, et al.. (2019). A High-throughput <em>Shigella</em>-specific Bactericidal Assay. Journal of Visualized Experiments. 3 indexed citations

15.

Frenck, Robert W., Shahida Baqar, William Alexander, et al.. (2018). A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei. Vaccine. 36(32). 4880–4889. 31 indexed citations

16.

Turbyfill, K. Ross, et al.. (2018). Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex. mSphere. 3(2). 34 indexed citations

17.

Kaminski, Robert W., et al.. (2013). Multiplexed immunoassay to assess Shigella-specific antibody responses. Journal of Immunological Methods. 393(1-2). 18–29. 11 indexed citations

18.

Barnoy, Shoshana, Shahida Baqar, Robert W. Kaminski, et al.. (2011). Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection. Vaccine. 29(37). 6371–6378. 25 indexed citations

19.

Ginkel, Frederik W. van, John L. VanCott, Robert W. Kaminski, & Thomas C. VanCott. (2003). Measurement of HIV-1 Specific and Total Antibody Secreting Cells by ELISPOT. Humana Press eBooks. 17. 283–292. 1 indexed citations

20.

VanCott, Thomas C., Robert W. Kaminski, John R. Mascola, et al.. (1998). HIV-1 Neutralizing Antibodies in the Genital and Respiratory Tracts of Mice Intranasally Immunized with Oligomeric gp160. The Journal of Immunology. 160(4). 2000–2012. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact